|
Immunotherapy
Citations 31-40 of 577 total displayed.
|
Past content
(since Jun 2000):
|
Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: results of a phase 2 multicenter clinical trial
- Tanzina Haque, Gwen M. Wilkie, Marie M. Jones, Craig D. Higgins, Gillian Urquhart, Phoebe Wingate, David Burns, Karen McAulay, Marc Turner, Christopher Bellamy, Peter L. Amlot, Deirdre Kelly, Alastair MacGilchrist, Maher K. Gandhi, Anthony J. Swerdlow, and Dorothy H. Crawford
Blood 2007; 110: 1123-1131.
[Abstract]
[Full text]
[PDF]
High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe systemic sclerosis: long-term follow-up of the US multicenter pilot study
- Richard A. Nash, Peter A. McSweeney, Leslie J. Crofford, Muneer Abidi, Chien-Shing Chen, J. David Godwin, Theodore A. Gooley, Leona Holmberg, Gretchen Henstorf, C. Fred LeMaistre, Maureen D. Mayes, Kevin T. McDonagh, Bernadette McLaughlin, Jerry A. Molitor, J. Lee Nelson, Howard Shulman, Rainer Storb, Federico Viganego, Mark H. Wener, James R. Seibold, Keith M. Sullivan, and Daniel E. Furst
Blood 2007; 110: 1388-1396.
[Abstract]
[Full text]
[PDF]
Antibody-drug conjugates targeted to CD79 for the treatment of non-Hodgkin lymphoma
- Andrew G. Polson, Shang-Fan Yu, Kristi Elkins, Bing Zheng, Suzanna Clark, Gladys S. Ingle, Dionysos S. Slaga, Lynne Giere, Changchun Du, Christine Tan, Jo-Anne Hongo, Alvin Gogineni, Mary J. Cole, Richard Vandlen, Jean-Philippe Stephan, Judy Young, Wesley Chang, Suzie J. Scales, Sarajane Ross, Dan Eaton, and Allen Ebens
Blood 2007; 110: 616-623.
[Abstract]
[Full text]
[PDF]
Costimulatory molecule-targeted immunotherapy of cutaneous graft-versus-host disease
- Juyang Kim, Hye J. Kim, Keunhee Park, Jiyoung Kim, Hye-Jeong Choi, Hideo Yagita, Seok H. Nam, Hong R. Cho, and Byungsuk Kwon
Blood 2007; 110: 776-782.
[Abstract]
[Full text]
[PDF]
CD4 cells can be more efficient at tumor rejection than CD8 cells
- Ainhoa Perez-Diez, Nathalie T. Joncker, Kyungho Choi, William F. N. Chan, Colin C. Anderson, Olivier Lantz, and Polly Matzinger
Blood 2007; 109: 5346-5354.
[Abstract]
[Full text]
[PDF]
A novel proteoliposomal vaccine elicits potent antitumor immunity in mice
- Mircea C. Popescu, Richard J. Robb, Michael M. Batenjany, Lawrence T. Boni, Mary E. Neville, Robin W. Pennington, Sattva S. Neelapu, and Larry W. Kwak
Blood 2007; 109: 5407-5410.
[Abstract]
[Full text]
[PDF]
Eradication of lymphoma by CD8 T cells following anti-CD40 monoclonal antibody therapy is critically dependent on CD27 costimulation
- Ruth R. French, Vadim Y. Taraban, Graham R. Crowther, Tania F. Rowley, Juliet C. Gray, Peter W. Johnson, Alison L. Tutt, Aymen Al-Shamkhani, and Martin J. Glennie
Blood 2007; 109: 4810-4815.
[Abstract]
[Full text]
[PDF]
Bortezomib enhances dendritic cell (DC)–mediated induction of immunity to human myeloma via exposure of cell surface heat shock protein 90 on dying tumor cells: therapeutic implications
- Radek Spisek, Anna Charalambous, Amitabha Mazumder, David H. Vesole, Sundar Jagannath, and Madhav V. Dhodapkar
Blood 2007; 109: 4839-4845.
[Abstract]
[Full text]
[PDF]
Adoptive transfer of tumor-primed, in vitro–activated, CD4+ T effector cells (TEs) combined with CD8+ TEs provides intratumoral TE proliferation and synergistic antitumor response
- Li-Xin Wang, Suyu Shu, Mary L. Disis, and Gregory E. Plautz
Blood 2007; 109: 4865-4876.
[Abstract]
[Full text]
[PDF]
Prognostic impact of immunohistochemically defined germinal center phenotype in diffuse large B-cell lymphoma patients treated with immunochemotherapy
- Heidi Nyman, Magdalena Adde, Marja-Liisa Karjalainen-Lindsberg, Minna Taskinen, Mattias Berglund, Rose-Marie Amini, Carl Blomqvist, Gunilla Enblad, and Sirpa Leppä
Blood 2007; 109: 4930-4935.
[Abstract]
[Full text]
[PDF]
|
|
